Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
OmniTier
AddedFeb 16, 2024
UpdatedJun 18, 2026
OmniTier

OmniTier

OmniTier Storage, a US tech firm, provides advanced computation solutions for genetics and precision analysis.

HQ
San Jose, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded in 2015 and based in Santa Clara, California, OmniTier is a technology company dedicated to solving complex computation problems in genetics and precision analysis. The company's core mission is to deliver affordable precision medicine solutions that enhance healthcare outcomes. OmniTier offers end-to-end genomic analysis through standalone appliances that are fast, accurate, secure, low-cost, and scalable, empowering researchers and clinicians to implement custom methodologies.

OmniTier has made significant strides in the field of genomics, with notable affiliations including collaborations with institutions like NCCHD in Japan, which demonstrated improved diagnostic rates for rare diseases using OmniTier’s technology. The company has garnered attention for its innovative approach to genomic analysis, making a substantial impact on precision medicine and healthcare research.

OmniTier - Similar Companies

OmicsCraft logo

OmicsCraft

omicscraft.com

Navipoint Genomics logo

Navipoint Genomics

GenomOncology logo

GenomOncology

genomoncology.com

Genome Insight logo

Genome Insight

Ultima Genomics logo

Ultima Genomics

ultimagenomics.com

Unite Genomics logo

Unite Genomics

Arima Genomics logo

Arima Genomics

arimagenomics.com

Spatial Genomics logo

Spatial Genomics

Paragon Genomics logo

Paragon Genomics

Jumpcode Genomics logo

Jumpcode Genomics

Ontera logo

Ontera

ontera.bio

Omni Biosciences logo

Omni Biosciences

Base5 Genomics logo

Base5 Genomics

b5genomics.com

CyOmics logo

CyOmics

Geneformics logo

Geneformics

OmniTier - Quick Facts

Who are OmniTier's competitors?

Companies similar to OmniTier include OmicsCraft, Navipoint Genomics, GenomOncology and Genome Insight.

When was OmniTier founded?

OmniTier was founded in 2015.

Where is OmniTier's headquarters located?

OmniTier's headquarters is located in San Jose, CA, US.

When was OmniTier's last funding round?

OmniTier's most recent funding round was for $3M (USD) in August 2015.

How much has OmniTier raised to-date?

As of Aug 26, 2015, OmniTier has raised a total of $3M (USD).

How many employees does OmniTier have?

OmniTier has 25 employees as of Feb 5, 2024.

OmniTier - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Genomic Analysis
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software